Walleye Trading’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-6,900
| Closed | -$546K | – | 4403 |
|
|
2025
Q4 | $546K | Buy |
6,900
+1,800
| +35% | +$136K | ﹤0.01% | 2773 |
|
|
2025
Q3 | $334K | Buy |
5,100
+900
| +21% | +$43.9K | ﹤0.01% | 3018 |
|
|
2025
Q2 | $166K | Sell |
4,200
-5,400
| -56% | -$177K | ﹤0.01% | 3346 |
|
|
2025
Q1 | $290K | Sell |
9,600
-4,800
| -33% | -$157K | ﹤0.01% | 2862 |
|
|
2024
Q4 | $503K | Buy |
14,400
+11,800
| +454% | +$441K | ﹤0.01% | 2634 |
|
|
2024
Q3 | $104K | Sell |
2,600
-18,400
| -88% | -$856K | ﹤0.01% | 3296 |
|
|
2024
Q2 | $1M | Sell |
21,000
-32,100
| -60% | -$1.32M | ﹤0.01% | 2075 |
|
|
2024
Q1 | $2.3M | Buy |
53,100
+46,800
| +743% | +$2.23M | ﹤0.01% | 1648 |
|
|
2023
Q4 | $319K | Sell |
6,300
-7,600
| -55% | -$364K | ﹤0.01% | 3449 |
|
|
2023
Q3 | $631K | Buy |
13,900
+5,300
| +62% | +$219K | ﹤0.01% | 2753 |
|
|
2023
Q2 | $353K | Sell |
8,600
-2,700
| -24% | -$104K | ﹤0.01% | 3044 |
|
|
2023
Q1 | $404K | Buy |
11,300
+5,800
| +105% | +$218K | ﹤0.01% | 2978 |
|
|
2022
Q4 | $208K | Buy |
5,500
+2,800
| +104% | +$118K | ﹤0.01% | 3544 |
|
|
2022
Q3 | $119K | Sell |
2,700
-1,500
| -36% | -$63.2K | ﹤0.01% | 3984 |
|
|
2022
Q2 | $155K | Buy |
+4,200
| New | +$158K | ﹤0.01% | 3883 |
|
|
2022
Q1 | – | Sell |
-7,700
| Closed | -$234K | – | 5574 |
|
|
2021
Q4 | $234K | Sell |
7,700
-21,800
| -74% | -$686K | ﹤0.01% | 3734 |
|
|
2021
Q3 | $989K | Buy |
29,500
+21,600
| +273% | +$814K | ﹤0.01% | 2217 |
|
|
2021
Q2 | $315K | Buy |
7,900
+7,500
| +1,875% | +$294K | ﹤0.01% | 3436 |
|
|
2021
Q1 | $18K | Sell |
400
-17,800
| -98% | -$993K | ﹤0.01% | 4565 |
|
|
2020
Q4 | $1.03M | Sell |
18,200
-24,600
| -57% | -$1.23M | ﹤0.01% | 1948 |
|
|
2020
Q3 | $2.03M | Sell |
42,800
-8,800
| -17% | -$489K | 0.01% | 1113 |
|
|
2020
Q2 | $3.04M | Sell |
51,600
-13,500
| -21% | -$751K | 0.02% | 811 |
|
|
2020
Q1 | $3.08M | Sell |
65,100
-200
| -0.3% | -$11.1K | 0.02% | 596 |
|
|
2019
Q4 | $3.94M | Buy |
65,300
+64,500
| +8,063% | +$3.84M | 0.03% | 715 |
|
|
2019
Q3 | $48K | Sell |
800
-53,200
| -99% | -$3.47M | ﹤0.01% | 3583 |
|
|
2019
Q2 | $3.47M | Sell |
54,000
-4,200
| -7% | -$297K | 0.03% | 674 |
|
|
2019
Q1 | $4.72M | Sell |
58,200
-4,200
| -7% | -$271K | 0.04% | 525 |
|
|
2018
Q4 | $3.37M | Buy |
62,400
+29,300
| +89% | +$1.49M | 0.02% | 696 |
|
|
2018
Q3 | $1.71M | Buy |
33,100
+17,400
| +111% | +$818K | 0.01% | 1497 |
|
|
2018
Q2 | $654K | Buy |
+15,700
| New | +$696K | ﹤0.01% | 2560 |
|
Other funds holding IONS
VPM
VCM
Walleye Trading's IONS Position: Q2 2025 in Review
Walleye Trading sold out of Ionis Pharmaceuticals (IONS) in Q2 2025, closing a stake of 9,361 shares — an estimated $306K sold.
Walleye Trading first reported a position in IONS in Q4 2015 and held it in 20 quarters. The position peaked at $1.58M in Q1 2020. 362 funds tracked by Wall St. Rank hold IONS as of Q2 2025.
- Walleye Trading reported no remaining Ionis Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
- Walleye Trading sold 9,361 Ionis Pharmaceuticals shares in Q2 2025, an estimated $306K.
- Walleye Trading first reported a position in Ionis Pharmaceuticals in Q4 2015 and held it in 20 quarters.
- Walleye Trading's Ionis Pharmaceuticals position peaked at $1.58M in Q1 2020.
- 362 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2025.
Based on Walleye Trading's 13F filing for Q2 2025, filed 13 Aug 2025.